Kelly Blackburn - Insider Trading & Ownership

Entity
Individual
Location
C/O Atyr Pharma, Inc., 3545 John Hopkins Court, Suite 250, San Diego, CA
Summary
The estimated net worth of Kelly Blackburn is at least $248K dollars as of January 26, 2024. Kelly Blackburn is the SVP, Clinical Development of CervoMed Inc. and owns shares of CervoMed Inc. (CRVO) stock worth about $248K.
All Insider Reports
All Insider Reports

Ownership of Kelly Blackburn

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CRVO CervoMed Inc. SVP, Clinical Development $248K Jan 26, 2024

Insider Transactions Reported by Kelly Blackburn:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.